Inteum Company
Links
seedsprint
Visible Legacy
RSS
News & Resources
Inteum Company News
Inteum Library
Subscribe
Search Results - bmp
3
Results
Sort By:
Published Date
Updated Date
Title
ID
Descending
Ascending
MODULATING BONE MORPHOGENIC PROTEIN (
BMP
) SIGNALING IN THE TREATMENT OF ALZHEIMER’S DISEASE
MODULATING BONE MORPHOGENIC PROTEIN (
BMP
) SIGNALING IN THE TREATMENT OF ALZHEIMER’S DISEASE Researchers at Stanford University have described a novel therapeutic target for Alzheimer’s disease. Alzheimer’s disease (AD) presents a large public health burden, effecting an estimated 5.5 million people in the United States and occurring...
Published: 4/13/2023
|
Inventor(s):
Michael Clarke
,
Jane Antony
,
Maddalena Adorno
,
Elizabeth Chen
,
Benedetta n di Robilant
,
Felicia Reinitz
Keywords(s):
Alzheimer’s Disease
,
BMP
,
Inhibitor
,
Neural Progenitor
,
Stem Cell
Category(s):
Technology Classifications > Biology
Novel ACRV1/ALK2 Inhibitors and Methods for Inhibiting
BMP
Signaling for the Treatment of Fibrodysplasia Ossificans Progressiva (FOP)
This technology includes the identification and use of novel ACRV1/ALK2 inhibitors for the treatment of fibrodysplasia ossificans progressiva (FOP), an autosomal-dominant rare disease that affects one person in every 1-2 million. FOP is characterized by malformation of the great (big) toes during embryonic development and by progressive heterotopic...
Published: 10/28/2024
|
Inventor(s):
Jian-kang Jiang
,
Khalida Shamim
,
Philip Sanderson
,
Wei Zheng
,
Xiuli Huang
,
Gregory Tawa
,
Asaf Alimardanov
,
Arthur Lee
,
Junfeng Huang
,
Wenwei Huang
Keywords(s):
ALK2
,
BMP
,
INHIBITING
,
Inhibitors
,
Methods
,
Novel
,
SIGNALING
,
VGXXXX
,
WIXXXX
,
WKXXXX
,
XEXXXX
Category(s):
TherapeuticArea > Endocrinology
,
Application > Therapeutics
,
Application > Research Materials
COMPOSITIONS AND METHODS FOR MODULATING LEFTY AND
BMP
PROTEINS
COMPOSITIONS AND METHODS FOR MODULATING LEFTY AND
BMP
PROTEINS Researchers at Stanford, funded in part by the Chan Zuckerberg Biohub, have surprisingly found that LEFTY1 suppresses not only the SMAD2/3 signaling pathway (a pathway activated by Nodal signaling) but also the SMAD1/5/8 signaling pathway (a pathway activated by BMP proteins, including...
Published: 9/30/2024
|
Inventor(s):
Michael Clarke
,
Neethan Lobo
,
Maider Ugalde
Keywords(s):
BMP
,
Breast Cancer
,
Cancer
,
LEFTY
,
Neoplasm
,
TGF-β Superfamily
Category(s):
Technology Classifications > Biology